Jean–Louis Jouve

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

Julien Edeline, M. Benabdelghani, Aurélie Bertaut et al. · Journal of Clinical Oncology · 2019 · 529 citations

Medicine, Oncology, Surgery +11

Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients

Thomas Aparicio, Jean–Louis Jouve, Laurent Teillet et al. · Journal of Clinical Oncology · 2013 · 215 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Arterial Embolotherapy for Endoscopically Unmanageable Acute Gastroduodenal Hemorrhage: Predictors of Early Rebleeding

Romaric Loffroy, Boris Guiu, Philippe d’Athis et al. · Clinical Gastroenterology and Hepatology · 2009 · 205 citations · Full text

Medicine, Surgery, Hemostasis +6

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma

Jean–Louis Jouve, Thierry Lecomte, Olivier Bouché et al. · Journal of Hepatology · 2019 · 114 citations

Medicine, Oncology, Pharmacology +13